+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Immunotherapy"

Global CAR-T Cell Therapy Market: Size, Forecasts, Trials & Trends, 2023 - Product Thumbnail Image

Global CAR-T Cell Therapy Market: Size, Forecasts, Trials & Trends, 2023

  • Report
  • November 2023
  • 321 Pages
  • Global
From
Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective - Product Thumbnail Image

Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective

  • Report
  • August 2023
  • 267 Pages
  • Global
From
Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028

  • Report
  • December 2023
  • 220 Pages
  • Global
From
Global Peptide Cancer Drug Market, Dosage, Price, Sales and Clinical Trials Insight 2029 - Product Thumbnail Image

Global Peptide Cancer Drug Market, Dosage, Price, Sales and Clinical Trials Insight 2029

  • Report
  • June 2023
  • 600 Pages
  • Global
From
Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase II, Phase III), Indication - Forecast 2024-2030 - Product Thumbnail Image

Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase II, Phase III), Indication - Forecast 2024-2030

  • Report
  • March 2024
  • 197 Pages
  • Global
From
Global PD-1 & PD-L1 Inhibitors Market by Product (Atezolizumab, Avelumab, Durvalumab), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Forecast 2024-2030 - Product Thumbnail Image

Global PD-1 & PD-L1 Inhibitors Market by Product (Atezolizumab, Avelumab, Durvalumab), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Forecast 2024-2030

  • Report
  • March 2024
  • 196 Pages
  • Global
From
Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Forecast 2024-2030 - Product Thumbnail Image

Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Forecast 2024-2030

  • Report
  • March 2024
  • 190 Pages
  • Global
From
Global Immuno Oncology Assays Market by Indication (Bladder Cancer, Colorectal Cancer, Lung Cancer), Product (Consumables, Software), Technology, Application - Forecast 2024-2030 - Product Thumbnail Image

Global Immuno Oncology Assays Market by Indication (Bladder Cancer, Colorectal Cancer, Lung Cancer), Product (Consumables, Software), Technology, Application - Forecast 2024-2030

  • Report
  • March 2024
  • 192 Pages
  • Global
From
Immuno-Oncology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Immuno-Oncology Clinical Trials Market Report 2023-2033

  • Report
  • September 2023
  • 249 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Drug Type (Monoclonal antibodies, Immunomodulators), By Cancer Type (Lung, Breast), By Service Type, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Drug Type (Monoclonal antibodies, Immunomodulators), By Cancer Type (Lung, Breast), By Service Type, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 98 Pages
  • Global
From
Global Liver Metastases Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Chemotherapy, Immunotherapy), Primary Cancer, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Global Liver Metastases Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Chemotherapy, Immunotherapy), Primary Cancer, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • January 2024
  • 100 Pages
  • Global
From
Liver Cancer Drug Market Size, Share & Trends Analysis Report By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Liver Cancer Drug Market Size, Share & Trends Analysis Report By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • October 2023
  • 92 Pages
  • Global
From
Sarcoma Drugs Market Size, Share & Trends Analysis Report By Treatment Type (Chemotherapy, Targeted Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Sarcoma Drugs Market Size, Share & Trends Analysis Report By Treatment Type (Chemotherapy, Targeted Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 93 Pages
  • Global
From
Bispecific Antibody Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report By Indication (Cancer, CNS Conditions), By Route of Administration, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report By Indication (Cancer, CNS Conditions), By Route of Administration, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • August 2023
  • 175 Pages
  • Global
From
Intratumoral Cancer Therapies Global Market Report 2024 - Product Thumbnail Image

Intratumoral Cancer Therapies Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Solid Tumor Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Solid Tumor Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Gastric Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Gastric Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Oncolytic Virus Therapy Global Market Report 2024 - Product Thumbnail Image

Oncolytic Virus Therapy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Head and Neck Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Eye Melanoma Global Market Report 2024 - Product Thumbnail Image

Eye Melanoma Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer. Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes. Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more